OTOS Antibody (N-term) Blocking peptide
€363.00
In stock
SKU
AC-BP13350a
Background:
Otospiralin is synthesized by nonsensory cells(fibrocytes) of the inner ear, and downregulation of otospiralin inguinea pigs leads to deafness (Lavigne-Rebillard et al., 2003[PubMed 12687421]).
Other Names:
Otospiralin, OTOS, OTOSP
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP13350a was selected from the N-term region of OTOS. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: OTOS
Gene ID: 150677
Primary Accession: Q8NHW6
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Otospiralin is synthesized by nonsensory cells(fibrocytes) of the inner ear, and downregulation of otospiralin inguinea pigs leads to deafness (Lavigne-Rebillard et al., 2003[PubMed 12687421]).
Other Names:
Otospiralin, OTOS, OTOSP
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP13350a was selected from the N-term region of OTOS. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: OTOS
Gene ID: 150677
Primary Accession: Q8NHW6
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review